Smartwatch-Style device could help cancer patients, but first: does it work in healthy people?
NCT ID NCT06366074
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests a wearable device that delivers mild electrical stimulation to the wrist (called transcutaneous electrical acustimulation, or TEA) in healthy adults. Participants wear the device for three days and use it for 60 minutes daily. The goal is to see if the device is easy to use and safe, with no serious skin irritation or pain. This early work is meant to pave the way for future studies in cancer patients who experience symptoms from chemotherapy.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Watch-Transcutaneous Electrical Acustimulation (TEA) device
What this could lead to
If successful, this device could be tested in cancer patients to help manage chemotherapy-induced symptoms like nausea or pain.
What could go wrong
This is a very early pilot study with no participants enrolled yet. It only tests usability and safety in healthy people, so it may not translate to patient benefits.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Michigan
Ann Arbor, Michigan, 48109, United States